Regulation of Apoptosis by Low Serum in Cells of Different Stages of Neoplastic Progression: Enhanced Susceptibility after Loss of a Senescence Gene and Decreased Susceptibility after Loss of a Tumor Suppressor Gene

Cancer Research

Volumn 54, Issue 15, 1994, Pages 4214-4223

  Preston, Gloria A ^a   Lang, Jason E ^a   Maronpot, Robert R ^a   Barrett1, J Carl ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DNA DEGRADATION; EMBRYO; EMBRYO CELL; ETIOLOGY; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMAL; APOPTOSIS; CELL DEATH; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CULTURE MEDIA; DNA REPLICATION; DNA, NEOPLASM; FLOW CYTOMETRY; G0 PHASE; G1 PHASE; GENE DELETION; GENES, TUMOR SUPPRESSOR; HAMSTERS; MESOCRICETUS; MICE; MICE, NUDE; NECROSIS; PRECANCEROUS CONDITIONS;

EID: 0028102003     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Wyllie, A.H., Kerr, J.F.R., and Currie, A.R. Cell death: the significance of apoptosis. Int. Rev. Cytol., 68: 251-306, 1980.
2. Kerr, J.F.R., Wyllie, A.H., and Currie, A.R. Apoptosis: a basic biological phenomenon with wide range implications in tissue kinetics. Br. J. Cancer, 26: 239-257, 1972.
3. Arends, M.J., and Wyllie, A.H. Apoptosis: mechanisms and role in pathology. Int. Rev. Exp. Pathol., 32: 223-256, 1991.
4. Williams, G.T. Programmed cell death: apoptosis and oncogenesis. Cell, 65: 1097-1098, 1991.
5. Yonish-Roauch, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A., and Oren, M. Wild-type p. 3 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature (Lond.), 352: 345-347, 1991.
6. Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B., and Costa, J. Induction of apoptosis by wild-type p. 3 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA, 89: 4495-4499, 1992.
7. Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.A., and Hancock, D.C. Induction of apoptosis in fibroblasts by c-myc. Cell, 69: 119-128, 1992.
8. Dedera, D.A., Waller, E.K., LeBrun, D.P., Sen-Majumdar, A., Stevens, M.E., Barsh, G.S., and Geary, M.L. Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice. Cell, 74: 833-843, 1993.
9. McDonnell, T.J., Deane, N., Platt, M., Nunez, G., Jaeger, U., McKearn, J.P., and Korsmeyer, S.J. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lympho-proliferation. Cell, 57: 79-88, 1989.
10. McDonnell, T.J., and Korsmeyer, S.J. Progression from lymphoid hyperplasia to high grade malignant lymphoma in mice transgenic for the t(14;18). Nature (Lond.), 349: 254-256, 1991.
11. Strasser, A., Harris, A.W., and Cory, S. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell, 67: 889-899, 1991.
12. Oren, M. The involvement of oncogenes and tumor suppressor genes in the control of apoptosis. Cancer Metastasis Rev., 11: 141-148, 1992.
13. Bursch, W., Lauer, B., Timmermann-Trosiener, I., Barthel, G., Schuppler, J., and Schulte-Hermann, R. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis (Lond.), 5: 453-458, 1984.
14. Thomassen, D.G., Gilmer, T.M., Annab, L.A., and Barrett, J.C. Evidence for multiple steps in neoplastic transformation of normal and preneoplastic Syrian hamster embryo cells following transfection with Harvey murine sarcoma virus oncogene (v-Ha-ras). Cancer Res., 45: 726-732, 1985.
15. Oshimura, M., Hesterberg, W.W., and Barrett, J.C. An early, nonrandom karyotypic change in immortal Syrian hamster cell lines transformed by asbestos: trisomy of chromosome 11. Cancer Genet. Cytogenet., 22: 225-237’, 1986.
16. Koi, M., and Barrett, J.C. Loss of tumor suppression function during chemically induced neoplastic progression of Syrian hamster embryo cells. Proc. Natl. Acad. Sci. USA, 83: 5992-5996, 1986.
17. Koi, M., Afshari, C.A., Annab, L.A., and Barrett, J.C. Role of a tumor suppressor gene in the negative control of anchorage-independent growth of Syrian hamster cells. Proc. Natl. Acad. Sci. USA, 86: 8773-8777, 1989.
18. Hao, Y., Crenshaw, T., Moulton, T., Newcomb, E., and Tycko, B. Tumour-suppressor activity of H19 RNA. Nature (Lond.), 365: 764-767, 1993.
19. Prasad, G.L., Fuldner, R.A., and Cooper, H.L. Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene. Proc. Natl. Acad. Sci. USA, 90: 7039-7043, 1993.
20. Owen, R.D., Hosoi, J., Montgomery, J.C., Wiseman, R., and Barrett, J.C. Coordinate regulation of collagen II(α1) and H19 expression in immortalized hamster cells. Cell Growth & Differ., 4: 1013-1021, 1993.
21. McConkey, D.J., Nicotera, P., Hartzell, P., Bellomo, G., Wyllie, A.H., and Orrenius, S. Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca2+ concentration. Arch. Biochem. Biophys., 269: 365-370, 1989.
22. Kyprianou, N., and Isaacs, J.T. Activation of programmed cell death in the rat ventral prostate. Endocrinology, 122: 552-562, 1988.
23. Kyprianou, K., English, H.F., and Isaacs, J.T. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res., 50: 3748-3753, 1990.
24. Kyprianou, N., English, H.F., Davidson, N.E., and Isaacs, J.T. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res., 51: 162-166, 1991.
25. Pardee, A.B. Molecules involved in proliferation of normal and cancer cells: presidential address. Cancer Res., 47: 1488-1491, 1987.
26. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493-501, 1992.
27. McLachlan, J.A., Wong, A., Degen, G.H., and Barrett, J.C. Morphological and neoplastic transformation of Syrian hamster embryo fibroblasts by diethylstilbestrol and its analogs. Cancer Res., 42: 3040-3045, 1982.
28. Oshimura, M., Annab, L.A., and Barrett, J.C. Long-term survival of normal, diploid Syrian hamster cells in tumors induced by transfection with v-Ha-ras and v-myc oncogenes. Cancer Lett., 45: 35-41, 1989.
29. Tamm, I., Kikuchi, T., Krueger, J., and Murphy, J.S. Dissociation between early loss of actin fibers and subsequent cell death in serum-deprived quiescent BALB/C-3T3 cells. Cell. Signal., 4: 675-686, 1992.
30. Kopp-Schneider, A., and Portier, C.J. Birth and death/differentiation rates of papillomas in mouse skin. Carcinogenesis (Lond.), 13: 973-978, 1992.
31. Topping, D., Griesemer, R.A., and Nettesheim, P. Development and fate of focal epithelial lesions in tracheal mucosa following exposure to 7, 12-dimethylbenz(a)anthracene. Cancer Res., 39: 4829-4837, 1979.
32. Umansky, S. The genetic program of cell death. Hypothesis and some applications: transformation, carcinogenesis, ageing. J. Theor. Biol., 97: 591-602, 1982.
33. Askew, D.S., Ashmun, R.A., Simmons, B.C., and Cleveland, J.L. Constitutive c-myc expression in an IL-3 dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene, 6: 1915-1922, 1991.
34. Oren, M. The involvement of oncogenes and tumor suppressor genes in the control of apoptosis. Cancer Metastasis Rev., 11: 141-148, 1992.
35. Eliyahu, D., Michalovitz, D., Eliyahu, S., Pinhasi-Kimhi, O., and Oren, M. Wild-type p. 3 can inhibit oncogene-mediated focus formation. Proc. Natl. Acad. Sci. USA, 86: 8763-8767, 1989.
36. Finlay, C.A., Hinds, P.W., and Levine, A.J. The p. 3 proto-oncogene can act as a suppressor of transformation. Cell, 57: 1083-1093, 1989.
37. Gaido, M.L., and Cidlowski, J.A. Identification, purification, and characterization of a calcium-dependent endonuclease (NUC18) from apoptotic rat thymocytes. J. Biol. Chem., 266: 18580-18585, 1991.
38. Jonczyk, P., White, A., Lum, K., Barrett, J.C., and Tlsty, T.L. Amplification potential in preneoplastic and neoplastic Syrian hamster embryo fibroblasts transformed by various carcinogens. Cancer Res., 53: 3098-3103, 1993.
39. Berges, R.R., Furuya, Y., Remington, L., English, H.F., Jacks, T., and Isaacs, J.T. Cell proliferation, DNA repair and p. 3 function are not required for programmed death of prostatic glandular cells induced by androgen ablation. Proc. Natl. Acad. Sci. USA, 90: 8910-8914, 1993.
40. Buttyan, R., Zakeri, Z., Lockshin, R., and Woglemuth, D. Cascade induction of c-fos, c-myc, and heat shock protein 70K transcripts during regression of rat ventral prostate gland. Mol. Endocrinol., 11: 650-656, 1988.
41. Fanidi, A., Harrington, E.A., and Evan, G.I. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature (Lond.), 359: 554-556, 1992.
42. Shi, Y., Glynn, J.M., Guilbert, L.J., Cotter, T.G., Bissonette, R.P., and Green, D.R. Role for c-Myc in activation-induced apoptotic cell death in T cell hybridomas. Science (Washington DC), 257: 212-214, 1992.
43. Afshari, C.A., Bivins, H.M., and Barrett, J.C. Utilization of a fos-lacZ plasmid to investigate c-fos expression in senescent and okadaic acid treated Syrian hamster embryo cells. J. Gerontol., in press, 1994.
44. Smeyne, R.J., Vendrell, M., Hayward, M., Baker, S.J., Miao, G.G., Schilling, K., Robertson, L.M., Curran, T., and Morgan, J.I. Continuous c-fos expression precedes programmed cell death in vivo. Nature (Lond.), 363: 166-169, 1993.
45. Bruno, S., Lassota, P., Giarett, W., and Darzynkiewicz, Z. Apoptosis of rat thymocytes triggered by prednisolone, camptothecin, or teniposide is selective to G0 ceils and is prevented by inhibitors of proteases. Oncol. Res., 4: 29-35, 1992.